Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?

  • Authors : Imai K; Department of Thoracic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. .; Kurihara N

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnostic imaging ; Neoplasm Staging*

  • Source: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Jun 03; Vol. 24 (1), pp. 69. Date of Electronic Publication: 2024 Jun Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330

Record details

×
Academic Journal

[Afatinib Treatment for Advanced Mixed Non-small Cell Lung Cancer 
with CRISPLD2-NRG1 Fusion: A Case Report and Literature Review].

  • Authors : Chen C; Respiratory and Critical Care Medicine, Chengfei Hospital, Chengdu 610073, China.; Yu Y

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 May 20; Vol. 27 (5), pp. 399-404.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

[Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA 
in Leptomeningeal Metastasis of Non-small Cell Lung Cancer].

  • Authors : Li Y; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.; Li X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/cerebrospinal fluid ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 May 20; Vol. 27 (5), pp. 376-382.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

[Progress and Discussion of Perioperative Targeted Therapy in Patients 
with EGFR-mutated Resectable Non-small Cell Lung Cancer].

  • Authors : Song P; Department of Thoracic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.; Cui Y

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/surgery

  • Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 May 20; Vol. 27 (5), pp. 383-390.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

[Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC].

  • Authors : Mao Y; Department of Oncology, Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.; Chinese PLA Medical School, Beijing 100853, China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 May 20; Vol. 27 (5), pp. 367-375.Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway.

  • Authors : Liao W; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao Special Administrative Region of China.; Zhang R

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Berberine*/Berberine*/Berberine*/pharmacology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jul; Vol. 176, pp. 116832. Date of Electronic Publication: 2024 Jun 07.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).

  • Authors : Taylor J; University of Caen Normandy, National Center for Scientific Research, Normandy University, Unit of Imaging and Therapeutic Strategies for Cancers and Cerebral Tissues (ISTCT)‑UMR6030, GIP CYCERON, F‑14074 Caen, France.; Dubois F

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/secondary ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/radiotherapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism

  • Source: International journal of oncology [Int J Oncol] 2024 Jul; Vol. 65 (1). Date of Electronic Publication: 2024 May 24.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations.

  • Authors : Xiong K; Department of Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China; Department of Cancer Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Jul; Vol. 53, pp. 101006. Date of Electronic Publication: 2024 May 17.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation.

  • Authors : Sholl LM; From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Sholl).; Awad M

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnosis

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Jul 01; Vol. 148 (7), pp. 757-774.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.

  • Authors : Wang R; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, PR China.; Zhong L

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Jul; Vol. 53, pp. 101004. Date of Electronic Publication: 2024 May 10.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  36,260 results for ""Lung Neoplasms""